SNPS · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $7.05B | $6.13B | $5.32B | $4.62B | $4.20B | $3.69B | $3.36B | $3.12B |
| Cost of Revenue | $1.62B | $1.25B | $1.03B | $898.01M | $861.78M | $794.69M | $752.95M | $735.90M |
| Gross Profit | $5.43B | $4.88B | $4.29B | $3.72B | $3.34B | $2.89B | $2.61B | $2.39B |
| Research & Development | $2.48B | $2.08B | $1.85B | $1.59B | $1.50B | $1.28B | $1.14B | $1.08B |
| Selling, General & Administrative | $769.65M | $568.50M | $376.68M | $313.55M | $322.99M | $284.53M | $229.22M | $262.56M |
| Operating Expenses | $4.52B | $3.53B | $3.01B | $2.57B | $2.61B | $2.27B | $2.09B | $2.02B |
| Operating Income | $914.93M | $1.36B | $1.27B | $1.15B | $734.79M | $620.14M | $520.23M | $360.23M |
| Interest Expense | — | — | $1.18M | $1.70M | $3.37M | $5.14M | $11.66M | $15.61M |
| Other Income / (Expense) | $924.94M | $194.98M | $34.93M | -$45.26M | $70.72M | $18.02M | $25.27M | $3.32M |
| Income Before Taxes | $1.39B | $1.51B | $1.31B | $1.10B | $805.51M | $638.16M | $545.51M | $363.54M |
| Provision for Income Taxes | $55.99M | $99.72M | $90.19M | $139.38M | $49.16M | -$25.29M | $13.14M | -$68.97M |
| Net Income | $1.33B | $2.26B | $1.23B | $984.59M | $757.52M | $664.35M | $532.37M | $432.52M |
| Basic EPS | $8.13 | $14.78 | $8.08 | $6.44 | $4.96 | $4.40 | $3.55 | $2.90 |
| Diluted EPS | $8.04 | $14.51 | $7.92 | $6.29 | $4.81 | $4.27 | $3.45 | $2.82 |
| Basic Shares Outstanding | 163.95M | 153.14M | 152.15M | 153.00M | 152.70M | 151.13M | 149.87M | 149.04M |
| Diluted Shares Outstanding | 165.66M | 155.94M | 155.19M | 156.49M | 157.34M | 155.71M | 154.19M | 153.39M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Oct 2026 | $10.65 | $10.36 | $10.83 | 7 | ↑0 ↓0 |
| Oct 2027 | $12.84 | $12.19 | $13.51 | 8 | ↑1 ↓0 |
| Oct 2028 | $15.13 | $14.98 | $15.28 | 2 | ↑0 ↓0 |